BGLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, BGL-3 acts as a tumor suppressor in CML and serves as a competitive endogenous RNA (ceRNA) that competes with microRNA (miRNA) for binding to downstream targets like PTEN (Guo et al., 2015).